文献速递药物不良反应与药物警戒

观察值与预期值分析在药物警戒工具包中的定位

Observed Versus Expected Analysis-How Does It Fit in the Pharmacovigilance Toolkit?
PubMed 文献 · Drug Saf · 2025-07-31

本文对比了观察值与预期值(O/E)分析与不相称性分析(DPA)在药物警戒中的优劣。COVID-19大规模疫苗接种安全监测使O/E分析算法化,更接近DPA。定性评估认为算法化O/E更易低估报告不足、对定义不对称更敏感、更依赖多样数据源。若将常规DPA调整为靶向DPA,有望替代算法化O/E用于信号评价。

要点

  • 算法化O/E分析更易低估报告不足且对条件定义不对称更敏感。
  • 算法化O/E更依赖暴露、背景发生率、风险窗口等数据或知识的准确性。
  • 靶向DPA经分层或亚组调整后有望从信号检测升级为信号评价方法。

核心结论

  • 算法化O/E分析更易低估报告不足、对条件定义不对称更敏感、更依赖多样数据源或医学知识。
  • 靶向DPA经分层或亚组调整后有望替代算法化O/E分析用于信号评价。

研究设计与样本

  • 对O/E分析与DPA的优劣势进行定性评估的综述性文章。

主要发现

  • COVID-19大规模疫苗接种安全监测中O/E分析使用规模空前,使其性质从医学与流行病学混合转为更算法化与自动化。
  • 算法化O/E更接近DPA,二者区别在于预期值的计算方式。
  • 算法化O/E更易低估报告不足,更易受条件定义不对称差异影响,更依赖可能不准确的暴露、背景发生率与风险窗口等数据或知识。

关键数值与推荐

  • 若对常规DPA进行分层或亚组调整形成靶向DPA,可考虑其替代算法化O/E分析。
  • 研究整合多种标准化DPA设置及偏倚度量(定性或定量)的敏感性分析框架可能比单纯估计背景发生率更有益。

临床怎么用

  • 在药物警戒信号评价中可优先考虑经分层或亚组调整的靶向DPA替代算法化O/E分析。
  • 使用O/E分析时需关注报告不足、条件定义不对称及数据源准确性对结果的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Observed versus expected (O/E) analyses have been used in an unprecedented scale for the safety monitoring of the COVID-19 mass vaccination. The extent of their usage changed its nature, which consisted of a mixture of medical expertise and epidemiology, into something more algorithmic and automated. By doing so, the observed versus expected analysis became closer to disproportionality analysis (DPA), which is also a type of observed versus expected analysis that differs in the way the expected is calculated. A qualitative assessment of the strengths and limitations of both methods concludes that the algorithmic O/E is more likely to underestimate under-reporting, is more likely to be sensitive to asymmetrical differences in the definition of the condition of interest, and is more dependent on a greater variety of data sources or medical knowledge that might not be accurate for emerging safety issues (exposure, background incidence rate, and risk window). Provided some adjustment (stratification and/or subgrouping) of the routine disproportionality into a targeted disproportionality occurs, which would account for the epidemiological specifics of the vaccine and event-of-interest, the targeted DPA has the potential to be promoted from a signal detection method into a signal evaluation method that could advantageously replace the algorithmic O/E analysis. Research on the setup of a sensitivity analysis framework integrating several standardized choices of disproportionality settings, along with measures (qualitative or quantitative) of the biases for each choice, could be more beneficial for the pharmacovigilance field than studies designed to estimate the background incidence rates of adverse events of special interest for the sole purpose of being used in O/E analyses.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Van Holle L. Observed Versus Expected Analysis-How Does It Fit in the Pharmacovigilance Toolkit? Drug Saf. 2025. PMID: 40742669. doi:10.1007/s40264-025-01584-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。